Somatuline Autogel: Acromegaly Self/Partner Injection Study

Inclusion Criteria: * The patient must have a clinical diagnosis of acromegaly * The patient must have been tested and shown to have a GH level less than or equal to 10 micrograms/L within 28 days prior to the baseline visit * The patient must be currently treated with Somatuline Autogel and have been stable on their current dose for at least 6 months immediately prior to screening * The patient must be able to store study medication in a refrigerator in their own home Exclusion Criteria: * The patient has had pituitary surgery (adenomectomy) within 6 months prior to screening * The patient has received pituitary radiotherapy within one year prior to screening * The patient is likely to require pituitary surgery (adenomectomy) or to receive radiotherapy during the study period * The patient is currently receiving a GH antagonist or a somatostatin analogue other than Somatuline Autogel